These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Eltabbakh GH; Piver MS; Hempling RE; Shin KH Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326 [TBL] [Abstract][Full Text] [Related]
15. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742 [TBL] [Abstract][Full Text] [Related]
16. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer. Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308 [TBL] [Abstract][Full Text] [Related]
17. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721 [TBL] [Abstract][Full Text] [Related]
18. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301 [TBL] [Abstract][Full Text] [Related]
19. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094 [TBL] [Abstract][Full Text] [Related]